{"id":"W2121576318","doi":"10.1016/j.ctrv.2009.12.012","title":"Lapatinib and HER2 status: Results of a meta-analysis of randomized phase III trials in metastatic breast cancer","year":2010,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Lapatinib; Medicine; Internal medicine; Metastatic breast cancer; Oncology; Breast cancer; Hazard ratio; Randomized controlled trial; Adverse effect; Cancer; Clinical trial; Discontinuation; Trastuzumab; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.008611131,0.002219849,0.01190779,0.00138642,0.0002842205,0.001666359,0.001367577,0.001139774,0.00271415],"category_scores_gemma":[0.01580587,0.001077357,0.01737169,0.002711738,0.0004529171,0.0009346945,0.0008376337,0.001811305,0.0002087119],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001645767,"about_ca_system_score_gemma":0.00166887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00398331,"about_ca_topic_score_gemma":0.01161746,"domain_scores_codex":[0.9957477,0.002556767,0.0007156881,0.0004647492,0.0003766361,0.0001385011],"domain_scores_gemma":[0.9919275,0.006274042,0.00111879,0.0002338231,0.0003166491,0.000129215],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01922529,0.00006142598,0.003993144,0.1778112,0.7588266,0.0001384581,0.0000744488,0.001135379,0.0006219428,0.0001622242,0.001933843,0.03601615],"study_design_scores_gemma":[0.004849555,0.0004622635,0.004342121,0.005051247,0.981882,0.0001215031,0.00003577819,0.000209265,0.0001813065,0.0002867128,0.002552614,0.00002553714],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01047013,0.9879313,0.0005279866,0.0001933058,0.0001529268,0.0001086362,0.0003412885,0.00002792706,0.0002464472],"genre_scores_gemma":[0.2479249,0.7467057,0.002533108,0.001012859,0.0002622239,0.0002682859,0.0007469676,0.00005290685,0.000493028],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9880922,"threshold_uncertainty_score":0.04554051,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4690951929631034,"score_gpt":0.5766936765117843,"score_spread":0.1075984835486809,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}